Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Quick Listen: Scrip’s Five Must-Know Things

Coronavirus Vaccines, Psoriasis, China Oncology And More

Executive Summary

Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.

Take a brief audio tour around Scrip’s Five Must-Know Things, in this episode covering major biopharmaceutical developments in the business week ended 24 July 2020.

Progress with coronavirus vaccines, a new contender in psoriasis, oncology strategy in China and a new trial in spinal muscular atrophy are on the table this week. 

Stories mentioned in this episode:

(Also see "New Pfizer/BioNTech COVID-19 Vaccine Data Confirm Prior Results, Show T-Cell Boost" - Scrip, 20 Jul, 2020.)

(Also see "Solid Phase I Results For AstraZeneca COVID-19 Vaccine, But Two Doses Needed To Hit Efficacy Goal" - Scrip, 20 Jul, 2020.)

(Also see "Lilly’s Mirikizumab Shows Superiority Vs. Cosentyx In Psoriasis" - Scrip, 17 Jul, 2020.)

(Also see "Roche Rides Partnership, Digital Wave To Widen China Oncology Drug Access" - Scrip, 20 Jul, 2020.)

(Also see "One Way To Get Ahead: Biogen To Test Spinraza Given After Novartis’s Zolgensma" - Scrip, 21 Jul, 2020.)


Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts